Streamline Health Announces Joint Marketing Agreement With nTelagent

CINCINNATI, July 17, 2012 /PRNewswire/ -- Streamline Health Solutions, Inc. (STRM), a leading provider of enterprise content management and business analytics solutions for healthcare organizations, today announced that it has entered into a joint marketing agreement with nTelagent, Inc., a leading provider of point-of-service solutions to support revenue cycle improvements within healthcare organizations' patient access departments. As part of the agreement, nTelagent will market the benefits of the Streamline Health business intelligence solutions and patient financial services workflows, and Streamline Health will promote the benefits of nTelagent's point-of-service solution to clients and prospects.

nTelagent's automated point-of-service solution provides patient access specialists with the information they need to maximize cash collections and handle the various situations that occur at point of registration. The nTelagent system enables providers to settle all accounts on the front end by guiding patient access staff through each patient encounter via real-time, customized scripts.

Streamline Health's business intelligence solution, OpportunityAnyWare, along with the company's ARWare and AuditWare workflows, help healthcare providers to achieve optimal financial performance while providing exceptional patient service and satisfaction. These solutions help healthcare organizations understand complex financial information that is often stored in disparate data repositories and structures data in a way that helps users make informed and actionable business decisions. Combined with nTelagent's retail point-of-service solutions, hospitals are able to create a complete process from point of service to patient billing that helps maximize overall cash collections and minimizes the cost to collect.

"We believe that combining OpportunityAnyWare and our patient financial services solutions with nTelagent's solutions will provide our mutual clients a broader capability to increase cash collections while using analytics to identify and address areas for improvement," said Robert E. Watson, president and chief executive officer of Streamline Health. "We are pleased to be adding another distribution channel partner who can strategically offer our solutions to their clients, while we have gained the opportunity to offer a new set of solutions to our clients."

"In the current healthcare market, having effective systems in place is critical for providers to maintain financial viability, and to continue giving patients exceptional care and service," explained Earl Winter, nTelagent CEO. "Partnering with Streamline Health, a proven leader in revenue cycle technology, allows nTelagent to strengthen our existing offerings to clients. In addition, our own expertise in helping hospitals increase upfront and overall collections will now be marketed to a larger number of companies, thanks to Streamline's network of clients."

About Streamline Health
Streamline Health provides solutions that help hospitals and physician groups improve efficiencies and business processes across the enterprise to enhance and protect revenues. Our enterprise content management solutions transform unstructured data into digital assets that seamlessly integrate with disparate clinical, administrative, and financial information systems. Our business analytics solutions provide real-time access to key performance metrics that enable healthcare organizations to identify and manage opportunities to maximize financial performance. Our integrated workflow systems automate and manage critical business activities to improve organizational accountability to drive both operational and financial performance. Across the revenue cycle, our solutions offer a flexible, customizable way to optimize the clinical and financial performance of any healthcare organization. Visit www.streamlinehealth.net for more information.

About nTelagent
nTelagent's fully integrated point-of-service solution for managing accounts receivable revolutionizes how healthcare providers interact with patients. The system enables providers to settle all accounts on the front end by guiding patient access staff through each patient encounter via real-time, customized scripts. From insurance verification to payment processing, registration is fast, simple and accurate for all patients: insured, uninsured and those qualifying for financial assistance. In addition to increasing upfront cash and cash on hand, nTelagent clients reduce AR days and bad debt, follow consistent practices on all registrations, identify accounts needing financial assistance, and provide dynamic reports for real-time end-user monitoring. Visit www.ntelagent.com for more information. For a video overview of nTelagent, visit  www.ntelagent.com/Video_and_Demo.html.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties and are no guarantee of future performance. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell the Company's products, the ability of the Company to control costs, availability of products obtained from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

View the original article here

Health Dialog Announces Next Generation of DECISION Dialog® Program

Sorry, I could not read the content fromt this page.

View the original article here

OPKO Health Announces Appointment of Juan F. Rodriguez as Chief Financial Officer

MIAMI--(BUSINESS WIRE)--

OPKO Health, Inc. (OPK) is pleased to announce the appointment of Juan F. Rodriguez as its new Senior Vice President and Chief Financial Officer. Mr. Rodriguez replaces Mr. Rao Uppaluri who is retiring.

Mr. Rodriguez brings to OPKO over 20 years of financial and business leadership experience, with over half of that in the life sciences field. Most recently, Mr. Rodriguez was serving as a consultant and advisor since 2007 to Cognitec Systems GmbH, a German software developer. From 1995 to 2007, prior to its acquisition by Abbott Laboratories, Mr. Rodriguez had been with Kos Pharmaceuticals, Inc., a publicly traded, specialty pharmaceutical company engaged in the development and commercialization of proprietary prescription products. During his twelve years at Kos, Mr. Rodriguez held various positions of increasing responsibility, including serving as Interim Chief Financial Officer, and last serving as Senior Vice President, Controller and Corporate Administration. Prior to joining Kos, Mr. Rodriguez was employed by Arthur Andersen LLP from 1991 to 1994. Mr. Rodriguez is a Certified Public Accountant and obtained his Bachelor of Accounting from Florida International University.

“We are extremely pleased to welcome Juan to OPKO. Juan’s industry knowledge and financial expertise will be invaluable as we continue to grow our company and execute our strategy to establish industry-leading positions in large and rapidly growing medical markets,” said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO.

Rao Uppaluri, has elected to retire from his role as the Chief Financial Officer of the Company, but will remain involved as a consultant to OPKO.

“On behalf of OPKO’s Board of Directors and the entire OPKO team, I want to thank Rao for his valuable contributions to OPKO,” said Dr. Frost. “Rao has been instrumental as a founding member of OPKO and leaves behind a strong, capable financial team. Our company and its employees have all benefited from Rao’s efforts and we wish him the very best in retirement. We are also delighted that Rao will continue to be involved with OPKO, ensuring a smooth transition.”

About OPKO Health, Inc.

OPKO is a multi-national biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.

This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning, including all non-historical statements about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies, prospects, growth opportunities, and management. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those described in our filings with the Securities and Exchange Commission, and risks inherent in funding, developing and obtaining regulatory approvals of new, commercially-viable and competitive products and treatments. In addition, forward-looking statements may also be adversely affected by general market factors, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new products and indications, manufacturing issues that may arise, patent positions and litigation, among other factors. The forward-looking statements contained in this press release speak only as of the date the statements were made, and, except as required by applicable law, we do not undertake any obligation to update forward-looking statements. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.

View the original article here

Rex Health Ventures Announces Inaugural Investment in N.C. Firm, Aerial BioPharma

Fri, Jul 13, 2012, 6:52 AM EDT - U.S. Markets open in 2 hrs 38 mins

Sorry, I could not read the content fromt this page.

View the original article here

Health Management Associates, Inc. Announces Second Quarter 2012 Earnings Conference Call and Webcast

NAPLES, Fla.--(BUSINESS WIRE)--

Health Management Associates, Inc. (HMA) announced today that on July 23, 2012 it will report results for its second quarter ended June 30, 2012.

Health Management will issue a press release after the market closes on Monday, July 23, 2012. At 11:00 a.m. (ET), the next day, Tuesday, July 24, 2012, management will host a conference call to discuss results in further detail. All interested investors are invited to participate in the conference call.

This conference call will also be simulcast on the Internet. To access the webcast, interested investors should go to the Investor Relations section of Health Management’s website located at www.hma.com or to www.streetevents.com. A replay of the conference call will be available on HMA’s website.

Health Management enables America's best local health care by providing the people, processes, capital and expertise necessary for its hospital and physician partners to fulfill their local missions of delivering superior health care services. Health Management, through its subsidiaries, operates 70 hospitals, with approximately 10,600 licensed beds, in non-urban communities located throughout the United States.

All references to "Health Management" and the “Company” used in this release refer to Health Management Associates, Inc. and its affiliates.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects," "estimates," "projects," "anticipates," "believes," “intends,” "plans," “may,” “continues,” “should,” "could" and other similar words. All statements addressing operating performance, events or developments that Health Management Associates, Inc. expects or anticipates will occur in the future, including but not limited to incurrence of indebtedness, projections of revenue, income or loss, capital expenditures, earnings per share, debt structure, bad debt expense, capital structure, repayment of indebtedness, the amount and timing of funds under the meaningful use measurement standard of various Healthcare Information Technology (“HCIT”) incentive programs, other financial items and operating statistics, statements regarding the plans and objectives of management for future operations, innovations, or market service development, statements regarding acquisitions, joint ventures, divestitures and other proposed or contemplated transactions (including but not limited to statements regarding the potential for future acquisitions and perceived benefits of acquisitions), statements of future economic performance, statements regarding legal proceedings and other loss contingencies, statements regarding market risk exposures, statements regarding the effects and/or interpretations of recently enacted or future health care laws and regulations, statements of the assumptions underlying or relating to any of the foregoing statements, and other statements which are other than statements of historical fact, are considered to be "forward-looking statements."

Because they are forward-looking, such statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Health Management Associates, Inc.'s most recent Annual Report on Form 10-K, including under the heading entitled "Risk Factors." Should one or more of these risks or uncertainties materialize, or should any of Health Management Associates, Inc.'s underlying assumptions prove incorrect, actual results could vary materially from those currently anticipated. In addition, undue reliance should not be placed on Health Management Associates, Inc.'s forward-looking statements. Except as required by law, Health Management Associates, Inc. disclaims any obligation to update its risk factors or to publicly announce updates to the forward-looking statements contained in this press release to reflect new information, future events or other developments.

View the original article here

Community Health Systems Announces Acquisition of York, Pennsylvania Hospital

FRANKLIN, Tenn.--(BUSINESS WIRE)--

Community Health Systems, Inc. (CYH) announced today that subsidiaries of the Company have acquired substantially all of the assets of Memorial Health Systems in York, Pennsylvania. The system includes 100-bed Memorial Hospital, the Surgical Center of York, and other outpatient and ancillary services. Memorial Hospital becomes the seventeenth Community Health Systems, Inc. affiliated hospital in Pennsylvania. The purchase agreement includes a commitment to construct a replacement hospital within five years of the closing date.

Commenting on today’s announcement, Wayne T. Smith, chairman, president and chief executive officer of Community Health Systems, Inc., said, “The acquisition of Memorial Health Systems extends our strong track record of growth and investment in Pennsylvania. The hospital’s medical staff and employees provide high-quality healthcare services in a competitive environment. We look forward to applying our proven operating strategies, physician recruitment resources, and access to capital to support the care they provide for their patients and to help bring life to a new, modern medical facility that advances clinical quality and the hospital experience.”

Located in the Nashville, Tennessee, suburb of Franklin, Community Health Systems, Inc. is one of the largest publicly-traded hospital companies in the United States and a leading operator of general acute care hospitals in non-urban and mid-size markets throughout the country. Through its subsidiaries, the Company currently owns, leases or operates 135 hospitals in 29 states with an aggregate of approximately 20,000 licensed beds. Its hospitals offer a broad range of inpatient and surgical services, outpatient treatment and skilled nursing care. In addition, through its subsidiary, Quorum Health Resources, LLC, the Company provides management and consulting services to non-affiliated general acute care hospitals located throughout the United States. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.”

Forward-Looking Statements

Statements contained in this news release regarding expected operating results, acquisition transactions or divestitures and other events are forward-looking statements that involve risk and uncertainties. Actual future events or results may differ materially from these statements. Readers are referred to the documents filed by Community Health Systems, Inc. with the Securities and Exchange Commission, including the Company’s annual report on Form 10-K, current reports on Form 8-K and quarterly reports on Form 10-Q. These filings identify important risk factors and other uncertainties that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

View the original article here

Alliance Health Networks Announces Sponsorship of 35 Stanford Medicine X ePatient Scholarships

Wed, Jun 13, 2012, 7:44 PM EDT - U.S. Markets closed

Sorry, I could not read the content fromt this page.

View the original article here

Alliance Health Networks Announces Sponsorship of 35 Stanford Medicine X ePatient Scholarships

Wed, Jun 13, 2012, 9:18 AM EDT - U.S. Markets open in 12 mins.

Sorry, I could not read the content fromt this page.

View the original article here

Magellan Health Services Announces Second Quarter 2012 Earnings Conference Call

AVON, Conn.--(BUSINESS WIRE)--

Magellan Health Services, Inc. (MGLN) today announced that it will release second quarter earnings results on Friday, July 27, 2012. Management will discuss the Company’s financial results, as well as its business strategy and outlook in a conference call to be held the same day from 10:00 to 11:00 a.m. Eastern time.

The press release detailing the Company’s second quarter 2012 earnings results will be issued at approximately 6:30 a.m. Eastern, and will be immediately available on the investor relations page at www.MagellanHealth.com.

To participate in the conference call, interested parties should call 1-888-566-8408 and reference the passcode Second Quarter 2012 Earnings Call approximately 15 minutes before the start of the call. The conference call also will be available via live webcast at Magellan's investor relations page at www.MagellanHealth.com.

A taped replay of the conference call will be available for one week following the call. Interested parties should call 1-800-925-0848 or 1-402-220-3072 (from outside the U.S.) to listen.

Those who plan to access the webcasts are encouraged to read Magellan's Annual Report on Form 10-K for the year ended 2011, filed with the Securities and Exchange Commission on February 28, 2012, and the subsequent Form 10-Q for the quarter ended March 31, 2012 filed with the Securities and Exchange Commission on April 27, 2012, for material information regarding Magellan's operational and financial results, including the section entitled “Risk Factors.”

About Magellan Health Services: Headquartered in Avon, Conn., Magellan Health Services, Inc. is a leading specialty health care management organization with expertise in managing behavioral health, radiology and specialty pharmaceuticals, as well as public sector pharmacy benefits programs. Magellan delivers innovative solutions to improve quality outcomes and optimize the cost of care for those we serve. As of March 31, 2012, Magellan’s customers include health plans, employers and government agencies, serving approximately 33.8 million members in our behavioral health business, 16.1 million members in our radiology benefits management segment, and 6.2 million members in our medical pharmacy management product. In addition, the specialty pharmaceutical segment served 41 health plans and several pharmaceutical manufacturers and state Medicaid programs. The company’s Medicaid Administration segment served 24 states and the District of Columbia. For more information, visit www.MagellanHealth.com.

Cautionary Statement: Certain of the statements made in the presentations may constitute forward-looking statements contemplated under the Securities Exchange Act of 1934 and the Securities Act of 1933, as amended that involve a number of risks and uncertainties. These forward-looking statements are based on management’s analysis, judgment, belief and expectations as of the date of such statements and are subject to known and unknown uncertainties and risks which could cause actual results to differ materially from those contemplated or implied by such forward-looking statements. Any forward-looking statements made in the presentations are qualified in their entirety by the more complete discussion of risks set forth in the section entitled “Risk Factors” in Magellan’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, filed with the Securities and Exchange Commission. Magellan undertakes no obligation to publicly revise such forward looking statements to reflect events or circumstances that arise after the date of such statements.

View the original article here

Health 2.0 Announces Winners of the Washington D.C. Health Data & Innovation Week Code-a-Thon: Preventing Obesity

Would You Rather Own Apple or Gold?Breakout

It may sound like some sort of riddle out a fairy tale, but the premise of our question is fairly profound; whether …

View the original article here

State Announces Intent to Award Four Medi-Cal Contracts to Health Net of California Subsidiary

Mon, Jun 4, 2012, 9:36 AM EDT - U.S. Markets close in 6 hrs 24 mins

Sorry, I could not read the content fromt this page.

View the original article here

China Health Labs & Diagnostics Ltd. announces financial results for the first quarter ended March 31, 2012

TSX-V: CHO
OTCQX: CHLBF

www.chinahealthlabs.com

TORONTO , May 31, 2012 /CNW/ - China Health Labs & Diagnostics Ltd. (" China Health" or the "Company") (TSXV:CHO; OTCQX:CHLBF), is pleased to announce the financial results for the first quarter ended March 31, 2012 .

In the first quarter, the Company maintained its position as a leading provider of total solutions for medical diagnostics and food safety testing in China , and made progress in delivering another year of growth in 2012.  In 2011, China Health generated revenue growth of 35% to $45.6 million and profit growth of 53% to over $8 million , compared to 2010.  In 2012, the Company expects to deliver growth in revenue and profits, compared to 2011.  The Company is not providing specific guidance for 2012, but expects growth in net profits to be lower than the 53% in 2011, due to increased investment in product development and human resources to support expansion into new regions of China .

Highlights from first quarter ended March 31, 2012 include: 

Revenue grew by 17% to $7.883 million and profit decreased by 37% to $0.772 million for the quarter ended March 31, 2012 compared to the quarter ended March 31, 2011 . Earnings per share decreased to $0.01 per basic and diluted share for the quarter ended March 31, 2012 compared to $0.02 for the quarter ended March 31, 2011 . Increased installed base of BK Clinlabs to 858 rural hospitals, including the installation of 41 BK Clinlabs in rural hospitals, with 40 installed in Chongqing and 1 in Xinjiang Uygur Autonomous Region. Increased sales in the urban hospital and labs sector by 25% to $4.327 million , mostly from increased sales of reagent and consumables. Launched five new products in March 2012 for its total lab solutions businesses, leveraging the Company's proprietary technologies, which are expected to generate new revenue and strong gross margins.  Delivered 63 rural mobile labs, one of the new products, which integrate the Company's point of care technology ("POCT") and lab managements system to deliver diagnostics to remote rural communities.  (See press releases dated March 15, 2012 and March 27 , 2012). The Company's first quarter revenue and profit are generally the lowest as a percentage of annual revenue, while the third and fourth quarters tend to comprise the largest percentage of revenue and profits, due to the seasonality of the Company's customers' purchasing and budgeting processes.  For example in 2011, the first quarter accounted for approximately 15% of annual revenue and profit, while the fourth quarter accounted for approximately 43% of annual revenue and 48% of annual profit.  The Company expects a similar seasonality of revenue and profit in 2012.  For further information on seasonality, please see the Company's financial statements and MD&A filed on SEDAR.

Subsequent to the first quarter, the Company entered into agreements that will increase its installed base of BK Clinlabs to 965 rural hospitals (see Press Release dated May 29 , 2012.)  In addition, the Company secured new sales orders for its high margin POCT field diagnostic total lab solutions.

"In the first quarter, our sales and product development teams worked with our customers to ensure that we can meet their needs for 2012 with new and existing products and solutions.  While the first quarter is always our slowest for revenue, our team works very hard to make sure that our solutions are worked into the annual budgets of our Chinese government customers," said Wilson Yao , CEO of China Health. "Based on our progress in the first quarter, we are confident that we can achieve our operating goals and generate another year of growth in revenue and profits in 2012."

Revenue for the quarter ended March 31, 2012 increased by 17% to $7.883 million , compared to $6.759 million for the quarter ended March 31, 2011 . The growth in revenue was largely due to increased sales in the rural hospital and clinics and large urban hospital and labs sectors, offset by a decrease in revenue for POCT solutions and products for defense and rescue agencies sector.  Revenue from POCT solutions and products are generally large sales orders that are not placed evenly throughout the year.  Based on discussions with customers, the Company expects revenue from POCT solutions and products to increase for the full year of 2012, compared to 2011. In 2011, revenue from large urban hospitals decreased by 6%, compared to overall growth of revenue of 35% in 2011.  In 2012, the Company expects the large urban sector to grow due to expected increased sales in recurring revenue of reagents and consumables.

Gross margin for the quarter ended March 31, 2012 increased by 6% to $4.147 million , compared to $3.894 million for the quarter ended March 31, 2011 due to overall increase in revenue. Gross margin as a percentage of revenue for the quarter ended March 31, 2012 was 53% compared to 58% for the quarter ended March 31, 2011 .

The decrease in gross margin as a percentage of revenue was due to changes in sales mix.  The lower gross margin as a percentage of revenue for the quarter ended March 31, 2012 was due to the decrease in revenue for the higher margin POCT solution and products for the quarter ended March 31, 2012 as compared to the same period in 2011.  The Company expects the gross margin for 2012 will be consistent with the gross margin for 2011 of 44%, but expects gross margin to vary on a quarterly basis due to changes in sales mix.

Administrative expenses for the quarter ended March 31, 2012 increased by 11% to $1.940 million , compared to $1.745 million for the quarter ended March 31, 2011 . The principal reason for the increase was higher overhead costs including new employees and expanded facilities to support a growing customer base and sales. Administrative expenses as a percentage of revenue decreased to 25% for the quarter ended March 31, 2012 , in comparison to 26% for the quarter ended March 31, 2011 .

Share-based compensation for the quarter ended March 31, 2012 was $0.081 million , compared with $0.188 million for the quarter ended March 31, 2011 . The share-based compensation expense is a result of stock options that vested during the period for stock options granted to employees in April 2011 and to management in September 2011 .

Research and development ("R&D") expenditures for the quarter ended March 31, 2012 decreased by 21% to $0.259 million , compared to $0.328 million for the quarter ended March 31 , 2011.  Research and development expense as a percentage of revenue were approximately 3% for the quarter ended March 31, 2012 , compared to 5% for the quarter ended March 31, 2011 . Research and development is focused on developing a full range of POCT solutions and improving the LMS system. The Company is accelerating product development to maintain its competitive advantages in the areas where it has developed unique proprietary solutions. Since the Company often collaborates with its customers to develop solutions, it is able to keep costs under control while developing products tailor made to customer needs.

Selling expenses for the quarter ended March 31, 2012 increased by 62% to $0.746 million , compared to $0.462 million for the quarter ended March 31, 2011 . Selling expense as a percentage of revenue was 9% for the quarter ended March 31, 2012 , compared to 7% for the quarter ended March 31, 2011 . Selling expenses are expected to increase in subsequent periods due to plans to expand the rural lab solution business to additional Chinese provinces and the food safety business to additional Chinese cities.

Government subsidy income for the quarter ended March 31, 2012 was $0.004 million , compared with $0.080 million for the quarter ended March 31, 2011 . From time to time, the Company will receive government subsidies for one of the PRC subsidiaries' that qualifies as a high-tech Company and is involved in developing the Company's lab management software, and also for another PRC subsidiary that is located in a certain district and is eligible for government grant based on outstanding performance.

Current income tax expense for the quarter ended March 31, 2012 was $0.371 million , compared with $0.322 million for the quarter ended March 31, 2011 .

The increase in income taxes is mainly due to an overall increase in taxable income being earned by the Company's PRC subsidiaries subject to the 25% tax rate, in comparison to the taxable income earned by the Company's PRC subsidiaries which are subject to preferential tax rates.

Operating profit for the quarter ended March 31, 2012 decreased by 16% to $1.206 million , compared to $1.439 million for the quarter ended March 31, 2011 . Profit for the quarter ended March 31, 2012 decreased by 37% to $0.772 million , compared to $1.224 million for the quarter ended March 31 , 2011.  Profit includes operating profit, interest expense, interest income and foreign exchange loss. Profit in the quarter ended March 31, 2012 represents 10% of revenue, compared to 18% of revenue for the quarter ended March 31, 2011 .

The decrease in operating profit and profit is due to the lower sales of POCT total lab solutions in the current quarter as compared to the same quarter last year, which generates higher margins than the Company's other products. Also, as the Company grows and continues its effort to expand its total lab solution businesses to other provinces and cities, expenses are expected to increase as a percentage of revenue.

Basic and fully diluted EPS was $0.01 for the quarter ended March 31, 2012 and $0.02 for the quarter ended March 31, 2011 . The decrease in EPS is due to the decrease in profit for the quarter ended March 31, 2012 as compared to the same period last year.

The average number of basic ordinary shares outstanding for the quarter ended March 31, 2012 was 65,606,686 (fully diluted 65,607,087), compared to 64,780,452 (fully diluted 67,183,226) average shares outstanding for the quarter ended March 31, 2011 .

Cash and short-term investments totaled $6.358 million as at March 31, 2012 , compared with $5.661 million of cash and short-term investments as of December 31 , 2011.  The Company's working capital as of March 31, 2012 was $26.509 million , compared with a $26.538 million working capital as of December 31 , 2011.  Working capital decreased by $0.029 million due to the decrease in total current assets of $1.994 million offset by the decrease in total current liabilities of $1.965 million .

The Company is well positioned to expand its business for rural lab total solutions, POCT lab solutions and food safety lab solutions.  However, the Company may need to access additional debt or equity funding if it seeks to accelerate its growth, if it enters into an agreement for a large number of total lab solutions or if it pursues suitable acquisition opportunities. 

Outlook & Growth Strategy

The Company believes that for the fiscal year 2012 it can continue its strong growth in revenue and profits and build on the leading position it has established in China in providing total lab solutions for rural hospitals and clinics, POCT solutions for military and emergency services, and food safety lab solutions, based on the size and growth of the Chinese market for medical diagnostics and food safety, the government support for the market and the Company's proprietary products and services and customer relationships.

In 2012, China Health intends to expand its business by focusing its efforts on expanding its sales network to additional Chinese provinces and cities in the areas where it has proprietary products and limited competition. Going forward, China Health expects revenue growth from its total lab solutions business lines to continue to be stronger than growth from its traditional business with large urban hospitals, and to comprise a higher percentage of revenue.

China Health will be hosting an investor conference call on Thursday, May 31, 2012 at 10:00 am (Eastern Time ).

The purpose of this conference call will be to provide investors with an update on the first quarter ended March 31, 2012 results of the Company. Representatives of China Health on the conference call will be:

Mr. Shiping (Wilson) Yao, President and Chief Executive Officer
Ms. Judyanna Chen , Chief Financial Officer
Mr. Kim Oishi , Member of the Board of Directors
Mr. Chao Zhang , Vice President, Finance

Following the update, a question and answer session will be held. To participate, the time and call-in instructions are as follows:

Participant Dial-In Number(s): North America Toll-Free Dial-In Number:  For Toronto and International Callers:   A Taped Replay will be available from 1:00 pm Eastern Time on May 31, 2012 to 11:59 pm Eastern Time on June 14, 2012 .

Taped Replay Toll Free Number: 1 (855) 859-2056

Taped Replay Local Dial-in Numbers:

Taped Replay Password: 83319568

About China Health Labs & Diagnostics Ltd.

China Health, operating in China as the Biochem Group, is a leading diagnostic lab solution provider for the public healthcare industry in China . The Company develops and sells Biochem Group branded and third-party medical diagnostic products and services to diagnostic facilities in China . Customers include large urban hospitals, rural hospitals, Chinese military and rescue operations, the Beijing government and third-party distributors.

In 2011, China Health had revenue of approximately $45.6 million , and intends to expand its business by focusing its efforts on expanding its sales network in three areas where it provides proprietary solutions, has limited competition and that are supported by Chinese government policy and budgets: BK Clinlab total lab solutions for rural hospitals and clinics, POCT solutions for military and emergency rescue services, and food safety solutions for large cities in China .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and information that are based on the beliefs of management and reflect China Health's current expectations.  When used in this news release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information.  The forward-looking statements and information in this news release includes information relating to new products generating new revenue and increasing gross margins; an increase in the stalled base of BK Clinlabs; the achievement of operating goals and another year of growth in revenue and profit in 2012; an increase in revenue from POCT solutions and products and from recurring revenue of reagents and consumables from the large urban sector; the gross margin for 2012 to be consistent with the gross margin for 2011, but to vary on a quarterly basis; an increase in selling expenses due to plans to expand the rural lab solution business to additional Chinese provinces and the food safety business to additional Chinese cities; an increase in expenses as a percentage of revenue as the Company expands its total lab solution businesses, the need to access additional debt or equity funding if the Company seeks to accelerate its growth, if it enters into an agreement for a large number of total lab solutions or if it pursues suitable acquisition opportunities; the continuation of the Company's strong growth in revenue and profits and the building of its leading position in China in providing total lab solutions for rural hospitals and clinics, POCT solutions for military and emergency services, and food safety lab solutions; expansion of the Company's business by focusing on expanding its sales network to additional Chinese provinces and cities in the areas where it has proprietary products and limited competition; and the revenue growth from the Company's total lab solutions business lines to continue to be stronger than growth from its traditional business with large urban hospitals, and to comprise a higher percentage of revenue.  The forward-looking information is based on certain assumptions, which could change materially in the future, including the assumption that the Company's products and services, operations, market, marketing plans and strategies, competitive conditions, future developments and proprietary protections continue as projected.  Such statements and information reflect the current view of China Health with respect to risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.  By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risk that the Company may not proceed or alter its growth strategy, the Company may not be able to obtain any required financing to accelerate growth on acceptable terms or at all, gross margins, revenue and profits may not continue to increase or increase less than expected, costs and expenses may increase greater than expected, and the Company may not be able to expand its business as expected through its sales network in any of the areas in which it has proprietary products, limited competition and strong government support.  These and other risks are further described under "Risk Factors" in the Company's year ended December 31, 2011 management's discuss and analysis dated April 16, 2012 , which is available on SEDAR and may be accessed at www.sedar.com.  When relying on China Health's forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events.  China Health has assumed a certain progression, which may not be realized.  It has also assumed that the material factors referred to above will not cause such forward-looking statements and information to differ materially from actual results or events.  However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF CHINA HEALTH AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE.  READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE.  WHILE CHINA HEALTH MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.

View the original article here

Heritage Health Solutions, Inc. Announces New President

Thu, May 31, 2012, 9:37 AM EDT - U.S. Markets close in 6 hrs 23 mins

Sorry, I could not read the content fromt this page.

View the original article here

Health Net Announces Appearance at Sanford C. Bernstein’s 28th Strategic Decisions Conference

LOS ANGELES--(BUSINESS WIRE)--

Health Net, Inc. (HNT) today announced that members of its management team are scheduled to present at Sanford C. Bernstein’s 28th Strategic Decisions Conference on May 30, 2012, at approximately 9:00 a.m. Eastern time.

A live webcast and replay of the presentation will be available at www.healthnet.com under “Investor Relations.” The webcast is open to all interested parties. The webcast should be accessed at least 15 minutes prior to its start time. Anyone listening to the webcast will be presumed to have read Health Net’s Annual Report on Form 10-K for the year ended December 31, 2011 and Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2012, and other reports filed by the company from time to time with the Securities and Exchange Commission.

About Health Net

Health Net, Inc. is a publicly traded managed care organization that delivers managed health care services through health plans and government-sponsored managed care plans. Its mission is to help people be healthy, secure and comfortable. Health Net, through its subsidiaries, provides and administers health benefits to approximately 5.6 million individuals across the country through group, individual, Medicare (including the Medicare prescription drug benefit commonly referred to as “Part D”), Medicaid, U.S. Department of Defense, including TRICARE, and Veterans Affairs programs. Health Net’s behavioral health services subsidiary, Managed Health Network, Inc., provides behavioral health, substance abuse and employee assistance programs to approximately 4.9 million individuals, including Health Net’s own health plan members. Health Net’s subsidiaries also offer managed health care products related to prescription drugs, and offer managed health care product coordination for multi-region employers and administrative services for medical groups and self-funded benefits programs.

For more information on Health Net, Inc., please visit Health Net’s website at www.healthnet.com.

Cautionary Statements

Health Net, Inc. and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act (“PSLRA”) of 1995, including statements in this and other press releases, in presentations, filings with the Securities and Exchange Commission (“SEC”), reports to stockholders and in meetings with investors and analysts. All statements in this press release, other than statements of historical information provided herein, may be deemed to be forward-looking statements and as such are intended to be covered by the safe harbor for “forward-looking statements” provided by PSLRA. These statements are based on management’s analysis, judgment, belief and expectation only as of the date hereof, and are subject to changes in circumstances and a number of risks and uncertainties. Without limiting the foregoing, statements including the words “believes,” “anticipates,” “plans,” “expects,” “may,” “should,” “could,” “estimate,” “intend,” “feels,” “will,” “projects” and other similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied or projected by the forward-looking information and statements due to, among other things, health care reform and other increased government participation in and regulation of health benefits and managed care operations, including the ultimate impact of the Affordable Care Act, which could materially adversely affect Health Net’s financial condition, results of operations and cash flows through, among other things, reduced revenues, new taxes, expanded liability, and increased costs (including medical, administrative, technology or other costs), or require changes to the ways in which Health Net does business; rising health care costs; continued slow economic growth or a further decline in the economy; negative prior period claims reserve developments; trends in medical care ratios; membership declines; unexpected utilization patterns or unexpectedly severe or widespread illnesses; rate cuts and other risks and uncertainties affecting Health Net’s Medicare or Medicaid businesses; Health Net’s ability to successfully participate in the dual-eligibles pilot programs; litigation costs; regulatory issues with federal and state agencies including, but not limited to, the California Department of Managed Health Care, the Centers for Medicare & Medicaid Services, the Office of Civil Rights of the U.S. Department of Health and Human Services and state departments of insurance; operational issues; failure to effectively oversee our third-party vendors; noncompliance by Health Net or Health Net’s business associates with any privacy laws or any security breach involving the misappropriation, loss or other unauthorized use or disclosure of confidential information; any liabilities of the Northeast business that were incurred prior to the closing of its sale as well as those liabilities incurred through the winding-up and running-out period of the Northeast business; investment portfolio impairment charges; volatility in the financial markets; and general business and market conditions. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included within Health Net’s most recent Annual Report on Form 10-K and subsequent Quarterly Report on Form 10-Q filed with the SEC, and the risks discussed in Health Net’s other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements. Except as may be required by law, Health Net undertakes no obligation to address or publicly update any of its forward-looking statements to reflect events or circumstances that arise after the date of this release.

View the original article here

Health Net, Inc. Announces 2012 Annual Meeting of Stockholders Webcast

LOS ANGELES--(BUSINESS WIRE)--

Health Net, Inc. (NYSE:HNT - News) will hold its 2012 Annual Meeting of Stockholders on Tuesday, May 22, 2012, at approximately 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time).

A live webcast and replay of the annual meeting and presentation will be available at www.healthnet.com under “Investor Relations.” The webcast is open to all interested parties. The company recommends that listeners access the webcast at least 15 minutes prior to its start time. Anyone listening to the webcast will be presumed to have read Health Net’s Annual Report on Form 10-K for the year ended December 31, 2011 and Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2012, and other reports filed by the company from time to time with the Securities and Exchange Commission.

About Health Net

Health Net, Inc. is a publicly traded managed care organization that delivers managed health care services through health plans and government-sponsored managed care plans. Its mission is to help people be healthy, secure and comfortable. Health Net, through its subsidiaries, provides and administers health benefits to approximately 5.6 million individuals across the country through group, individual, Medicare (including the Medicare prescription drug benefit commonly referred to as “Part D”), Medicaid, U.S. Department of Defense, including TRICARE, and Veterans Affairs programs. Health Net’s behavioral health services subsidiary, Managed Health Network, Inc., provides behavioral health, substance abuse and employee assistance programs to approximately 4.9 million individuals, including Health Net’s own health plan members. Health Net’s subsidiaries also offer managed health care products related to prescription drugs, and offer managed health care product coordination for multi-region employers and administrative services for medical groups and self-funded benefits programs.

For more information on Health Net, Inc., please visit Health Net’s website at www.healthnet.com.

Cautionary Statements

Health Net, Inc. and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act (“PSLRA”) of 1995, including statements in this and other press releases, in presentations, filings with the Securities and Exchange Commission (“SEC”), reports to stockholders and in meetings with investors and analysts. All statements in this press release, other than statements of historical information provided herein, may be deemed to be forward-looking statements and as such are intended to be covered by the safe harbor for “forward-looking statements” provided by PSLRA. These statements are based on management’s analysis, judgment, belief and expectation only as of the date hereof, and are subject to changes in circumstances and a number of risks and uncertainties. Without limiting the foregoing, statements including the words “believes,” “anticipates,” “plans,” “expects,” “may,” “should,” “could,” “estimate,” “intend,” “feels,” “will,” “projects” and other similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied or projected by the forward-looking information and statements due to, among other things, health care reform and other increased government participation in and regulation of health benefits and managed care operations, including the ultimate impact of the Affordable Care Act, which could materially adversely affect Health Net’s financial condition, results of operations and cash flows through, among other things, reduced revenues, new taxes, expanded liability, and increased costs (including medical, administrative, technology or other costs), or require changes to the ways in which Health Net does business; rising health care costs; continued slow economic growth or a further decline in the economy; negative prior period claims reserve developments; trends in medical care ratios; membership declines; unexpected utilization patterns or unexpectedly severe or widespread illnesses; rate cuts and other risks and uncertainties affecting Health Net’s Medicare or Medicaid businesses; Health Net’s ability to successfully participate in the dual-eligibles pilot programs; litigation costs; regulatory issues with federal and state agencies including, but not limited to, the California Department of Managed Health Care, the Centers for Medicare & Medicaid Services, the Office of Civil Rights of the U.S. Department of Health and Human Services and state departments of insurance; operational issues; failure to effectively oversee our third-party vendors; noncompliance by Health Net or Health Net’s business associates with any privacy laws or any security breach involving the misappropriation, loss or other unauthorized use or disclosure of confidential information; any liabilities of the Northeast business that were incurred prior to the closing of its sale as well as those liabilities incurred through the winding-up and running-out period of the Northeast business; investment portfolio impairment charges; volatility in the financial markets; and general business and market conditions. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included within Health Net’s most recent Annual Report on Form 10-K and subsequent Quarterly Report on Form 10-Q filed with the SEC, and the risks discussed in Health Net’s other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements. Except as may be required by law, Health Net undertakes no obligation to address or publicly update any of its forward-looking statements to reflect events or circumstances that arise after the date of this release.

View the original article here

Health Care REIT, Inc. Announces Western Regional Office Opening

TOLEDO, Ohio--(BUSINESS WIRE)--

Health Care REIT, Inc. (NYSE:HCN - News) announced today the opening of a Western Regional Office in Newport Beach, California. The company’s enhanced presence on the West Coast is a natural extension of Health Care REIT’s relationship investing strategy and the concentration of its portfolio in East and West Coast markets and top 31 MSA’s. The office will be led by Mercedes Kerr, Health Care REIT’s Senior Vice President – Marketing.

“The opening of our Western Regional Office underscores our commitment to leading seniors housing operators and health care providers in Western markets,” commented George L. Chapman, Chairman, Chief Executive Officer and President of Health Care REIT. “It will enable us to be better connected and to more rapidly respond to opportunities in this area.”

Health Care REIT distinguishes itself as a relationship-focused company, and the opening of a Western Regional Office will complement the company’s strategic focus. The expansion will enhance Health Care REIT’s presence in the West while providing a local base to support the needs of the company’s new and existing partners.

“Health Care REIT is taking a leadership role in the transformation of seniors housing and health care delivery systems in the Western regional market,” stated Mercedes Kerr. “I am excited about the many opportunities for our current and future partners on the West Coast.”

About Health Care REIT, Inc. Health Care REIT, Inc., an S&P 500 company with headquarters in Toledo, Ohio, is a real estate investment trust that invests across the full spectrum of seniors housing and health care real estate. The company also provides an extensive array of property management and development services. As of December 31, 2011, the company’s broadly diversified portfolio consisted of 937 facilities in 46 states. More information is available on the company’s website at www.hcreit.com.

View the original article here

Accretive Health Announces Termination of its Quality and Total Cost of Care Services Contract by Fairview Health ...

CHICAGO--(BUSINESS WIRE)--

Accretive Health, Inc. (NYSE: AH - News) said today that it has received notice of termination from Fairview Health Services of its Quality and Total Cost of Care (“QTCC”) services contract. The terms of the transition have yet to be determined. The Company will update its business outlook on its quarterly earnings call on May 9, 2012.

Accretive Health said that it regrets that the recent activities of the Minnesota Attorney General have created a situation where Fairview felt it necessary to cancel its work with the Company in QTCC. The Company intends to work with Fairview to preserve the good results that have been achieved and will continue to invest in this important area.

Accretive Health also said it has received reiterations of support from other clients who recognize the value of Accretive Health’s ability to help hospitals and other healthcare providers enhance their quality of care. This show of support is consistent with the Company’s mission of being a constructive and positive contributor to the American healthcare system.

About Accretive Health

Accretive Health partners with healthcare providers to help them more effectively manage their revenue cycles, strengthen their financial stability, and improve the quality of care they provide while reducing overall healthcare costs. Our people, processes and sophisticated integrated technology complement our clients' existing resources to enhance results for patients, physicians and staff. For more information, please visit www.accretivehealth.com.

Safe Harbor Statement

This document contains forward-looking statements, including statements regarding outstanding issues with the Minnesota Attorney General and the Company’s efforts to facilitate an orderly transition of its QTCC services at Fairview Health Services, which involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in our Annual Report on Form 10-K filed with the SEC on February 29, 2012, under the heading "Risk Factors". The words "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "would," “will,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that the expectations underlying any of our forward-looking statements are reasonable, these expectations may prove to be incorrect and all of these statements are subject to risks and uncertainties. Should one or more of these risks and uncertainties materialize, or should underlying assumptions, projections, or expectations prove incorrect, actual results, performance, financial condition, or events may vary materially and adversely from those anticipated, estimated, or expected.

All forward-looking statements included in this report are expressly qualified in their entirety by the foregoing cautionary statements. We wish to caution readers not to place undue reliance on any forward-looking statement that speaks only as of the date made and to recognize that forward-looking statements are predictions of future results, which may not occur as anticipated. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the uncertainties and factors described above, as well as others that we may consider immaterial or do not anticipate at this time. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. Our expectations reflected in our forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown uncertainties and factors, including those described above. The risks and uncertainties described above are not exclusive, and further information concerning us and our business, including factors that potentially could materially affect our financial results or condition or relationships with customers and potential customers, may emerge from time to time. We assume no, and we specifically disclaim any, obligation to update, amend, or clarify forward-looking statements to reflect actual results or changes in factors or assumptions affecting such forward-looking statements. We advise you, however, to consult any further disclosures we make on related subjects in our periodic reports that we file with or furnish to the U.S. Securities and Exchange Commission.

View the original article here

Health Management Announces 1st Quarter 2012 Results

Mon, Apr 23, 2012, 10:29 PM EDT - U.S. Markets closed

Sorry, I could not read the content fromt this page.

View the original article here

Vanguard Health Systems Announces Closing of $375.0 Million Senior Notes Offering

Vanguard Health Systems, Inc. (NYSE: VHS) (“Vanguard”) announced today that its wholly-owned subsidiaries, Vanguard Health Holding Company II, LLC (“VHS Holdco II”) and Vanguard Holding Company II, Inc. (together with VHS Holdco II, the “Issuers”), closed their private placement of an aggregate principal amount of $375.0 million of 7.750% Senior Notes due 2019 (the “New Notes”). The New Notes were issued pursuant to the indenture, dated as of January 26, 2011 (the “Indenture”), governing their existing 7.750% Senior Notes due 2019 (the “Existing Notes”). The New Notes were issued at an offering price of 99.25% plus accrued interest from February 1, 2012. The New Notes will be treated as a single series with the Existing Notes, except that (i) the New Notes are subject to a separate registration rights agreement and (ii) unless and until the New Notes are registered, the New Notes will have a different CUSIP number from that of the Existing Notes and will not be fungible with the Existing Notes.

The Issuers intend to use the net proceeds from the offering of the New Notes for general corporate purposes, which may include, but not be limited to, working capital, capital expenditures, acquisitions, the repayment of any outstanding indebtedness under Vanguard’s existing revolving credit facility, and to pay the fees and expenses incurred in connection with the offering.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy the New Notes. The New Notes were offered in a private placement to qualified institutional buyers pursuant to Rule 144A and outside the United States in compliance with Regulation S under the Securities Act of 1933, as amended (the “Securities Act”).

The New Notes have not been registered under the Securities Act, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Company Information and Forward-Looking Statements

About Vanguard Health Systems

Vanguard owns and operates 28 acute care and specialty hospitals and complementary facilities and services in metropolitan Chicago, Illinois; metropolitan Phoenix, Arizona; metropolitan Detroit, Michigan; San Antonio, Texas; Harlingen and Brownsville, Texas; and Worcester and metropolitan Boston, Massachusetts. Vanguard’s strategy is to develop locally branded, comprehensive healthcare delivery networks in urban markets.

This press release contains “forward-looking statements” within the meaning of the federal securities laws that are intended to be covered by safe harbors created thereby. Forward-looking statements are those statements that are based upon management’s plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, business trends and other information that is not historical information. These statements are based upon estimates and assumptions made by Vanguard’s management that, although believed to be reasonable, are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those projected. When used in this press release, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “forecasts,” “continues” or future or conditional verbs, such as “will,” “should,” “could” or “may,” and variations of such words or similar expressions are intended to identify forward-looking statements. These factors, risks and uncertainties include, but are not limited to: Vanguard’s high degree of leverage and interest rate risk; Vanguard’s ability to incur substantially more debt; operating and financial restrictions in Vanguard’s debt agreements; Vanguard’s ability to generate cash necessary to service its debt; weakened economic conditions and volatile capital markets; potential liability related to disclosures of relationships between physicians and Vanguard’s hospitals; post-payment claims reviews by governmental agencies could result in additional costs to Vanguard; Vanguard’s ability to grow its business and successfully implement its business strategies; Vanguard’s ability to successfully integrate The Detroit Medical Center, Valley Baptist Health System, and hospitals acquired in the future or to recognize expected synergies from such acquisitions; potential acquisitions could be costly, unsuccessful or subject Vanguard to unexpected liabilities; conflicts of interest that may arise as a result of Vanguard’s control by a small number of stockholders; the highly competitive nature of the healthcare industry; governmental regulation of the healthcare industry, including Medicare and Medicaid reimbursement levels in general and with respect to the impact of the Budget Control Act of 2011 and other future deficit reduction plans; a reduction or elimination of supplemental Medicare and Medicaid payments, including disproportionate share payments, indirect medical education/graduate medical education payments and other similar payments, would adversely impact Vanguard’s liquidity, results of operations and financial condition; pressures to contain costs by managed care organizations and other insurers and Vanguard’s ability to negotiate acceptable terms with these third party payers; Vanguard’s ability to attract and retain qualified management and healthcare professionals, including physicians and nurses; the currently unknown effect on Vanguard of the major federal healthcare reforms enacted by Congress in March 2010 or other potential additional federal or state healthcare reforms; potential adverse impact of known and unknown governmental investigations and audits; Vanguard’s failure to adequately enhance its facilities with technologically advanced equipment could adversely affect its revenues and market position; the availability of capital to fund Vanguard’s corporate growth strategy and improvement to its existing facilities; potential lawsuits or other claims asserted against Vanguard; Vanguard’s ability to maintain or increase patient membership in and to control costs of its managed healthcare plans; failure of the Arizona Health Care Cost Containment System (“AHCCCS”) to renew its contract with, or award future contracts to, Phoenix Health Plan would materially affect Vanguard’s business, profitability, financial condition and results of operations; Phoenix Health Plan’s ability to comply with the terms of its contract with AHCCCS, as noncompliance could subject it to fines, penalties or termination of its contract, which would materially affect Vanguard’s business, profitability, financial condition and results of operations; Vanguard’s inability to manage health plan claims expense within its health plans could reduce its profitability and adversely impact its liquidity and financial position; reductions in the enrollment of Vanguard’s health plans could have an adverse effect on its business and profitability; changes in general economic conditions nationally and regionally in Vanguard’s markets; Vanguard’s exposure to the increased amounts of and collection risks associated with uninsured accounts and the co-pay and deductible portions of insured accounts; dependence on Vanguard’s senior management team and local management personnel; volatility of professional and general liability insurance for Vanguard and the physicians who practice at its hospitals and increases in the quantity and severity of professional liability claims; Vanguard’s ability to achieve operating and financial targets and to maintain and increase patient volumes and control the costs of providing services, including salaries and benefits, supplies and other operating expenses; increased compliance costs from further government regulation of the healthcare industry and Vanguard’s failure to comply, or allegations of Vanguard’s failure to comply, with applicable laws and regulations; the geographic concentration of Vanguard’s operations; technological and pharmaceutical improvements that increase the cost of providing, or reduce the demand for, healthcare services and shift demand for inpatient services to outpatient settings; a failure of Vanguard’s information systems would adversely impact Vanguard’s ability to manage its operations; delays in receiving payments for services provided, especially from governmental payers; changes in revenue mix, including changes in Medicaid eligibility criteria and potential declines in the population covered under managed care agreements; costs and compliance risks associated with Section 404 of the Sarbanes-Oxley Act of 2002; material non-cash charges to earnings from impairment of goodwill associated with declines in the fair market value of Vanguard’s reporting units; volatility of materials and labor costs for, or state efforts to regulate, potential construction projects that may be necessary for future growth; changes in accounting practices; and Vanguard’s ability to demonstrate meaningful use of certified electronic health record technology and to receive the related Medicare or Medicaid incentive payments.

Vanguard’s forward-looking statements speak only as of the date made. Except as required by law, Vanguard undertakes no obligation to publicly update or revise any forward-looking statements contained herein, whether as a result of new information, future events or otherwise. Vanguard advises you, however, to consult any additional disclosures Vanguard makes in Vanguard’s other filings with the Securities and Exchange Commission. You are cautioned not to rely on such forward-looking statements when evaluating the information contained in this press release. In light of significant uncertainties inherent in the forward-looking statements included in this press release, you should not regard the inclusion of such information as a representation by Vanguard that the objectives and plans anticipated by the forward-looking statements will occur or be achieved or, if any of them do, what impact they will have on Vanguard’s financial condition, results of operations or cash flows.

View the original article here

Health Care REIT, Inc. Announces Pricing of $600 Million of 4.125% Senior Notes

Health Care REIT, Inc. (NYSE:HCN) today announced that it has priced $600 million in aggregate principal amount of 4.125% senior unsecured notes due April 1, 2019. The notes were priced at 99.694% of their face amount to yield 4.176%. Subject to customary closing conditions, the offering is expected to close on April 3, 2012.

The company intends to use the net proceeds from this offering to redeem or settle upon conversion approximately $126 million aggregate outstanding principal amount of its 4.75% convertible senior notes due 2026 at a redemption price of 100% of principal amount plus accrued and unpaid interest or the conversion price specified in those notes, as the case may be, to repay up to $226 million of certain secured indebtedness and, to the extent of remaining proceeds, for general corporate purposes, including investing in health care and seniors housing properties. Pending such use, the net proceeds may be invested in short-term, investment grade, interest-bearing securities, certificates of deposit or indirect or guaranteed obligations of the United States.

Barclays Capital Inc., J.P. Morgan Securities LLC, and UBS Securities LLC acted as joint book-running managers for the offering.

The offering is being made pursuant to Health Care REIT’s shelf registration statement on file with the Securities and Exchange Commission. A copy of the prospectus supplement and accompanying prospectus relating to the offering may be obtained by contacting Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by phone (toll free): 888-603-5847 or by e-mail: barclaysprospectus@broadridge.com; J.P. Morgan Securities LLC, 383 Madison Avenue, New York, NY 10179, attention: Investment Grade Syndicate Desk, or by telephone collect at 212-834-4533; or UBS Securities LLC, Attention: Prospectus Specialist, 299 Park Avenue, New York, NY 10171, or by telephone toll free at 877-827-6444, ext. 561 3884.

This press release is not an offer to sell, nor a solicitation of an offer to buy securities, nor shall there be any sale of these securities in any state or jurisdiction in which the offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Health Care REIT. Health Care REIT, Inc., an S&P 500 company with headquarters in Toledo, Ohio, is a real estate investment trust that invests across the full spectrum of seniors housing and health care real estate. The company also provides an extensive array of property management and development services. As of December 31, 2011, the company’s broadly diversified portfolio consisted of 937 properties in 46 states. More information is available on the company's website at www.hcreit.com.

Forward-Looking Statements

This document may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. When the company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The company’s expected results may not be achieved, and actual results may differ materially from expectations. This may be a result of various factors, including, but not limited to, those factors discussed in the prospectus supplement and related prospectus and in the company's reports filed from time to time with the Securities and Exchange Commission. Completion of the proposed offering is subject to various factors, including, but not limited to, customary closing conditions. The company assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.

View the original article here